Differential Regulation of the Stability of Cytokine mRNAs in Lipopolysaccharide-activated Blood Monocytes in Response to Interleukin-10
Open Access
- 1 August 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (33) , 20108-20112
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils.Journal of Experimental Medicine, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.Journal of Experimental Medicine, 1994
- Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.Journal of Experimental Medicine, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Macrophage deactivation by interleukin 10.Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991
- Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation.Journal of Clinical Investigation, 1990
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.Journal of Experimental Medicine, 1989
- Regulation of interleukin 3 gene induction in normal human T cells.Journal of Clinical Investigation, 1989
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989